Canadian corporate Aurora Cannabis has announced the launch of its first German-grown medical product amid easing restrictions on the German medical hash market.
Aurora announced this week the launch of its brand, IndiMed, which manufactures medical cannabis products at Aurora’s leading EU-GMP facility in Leuna, Germany.
The first product introduced through the IndiMed logo is Island Sweet Skunk, dried flower, sativa, 20% THC and less than 1% CBD, which is expected to be available on January 27.
The indimed product is grown in accordance with the EU-Good Agricultural and Harvesting Practices (GACP) and EU-GMP (Good Manufacturing Practices) directives. These commercial criteria apply to medicines intended to be imported into the European Union, thus ensuring safe pharmaceutical quality.
Aurora entered Europe in the mid-2010s, acquiring Germany’s Pedanios in 2017 to anchor its presence in the EU. In the late 2010s, it expanded to Italy, Nordic countries, and Poland through an approach of adapting to strict regulations, supplying medical cannabis, and investing in R&D. The company started trading on the NYSE in 2018, under the ticker symbol ACB.
This announcement comes at a favorable moment for Germany’s medical cannabis market, which removed cannabis from controlled substances drugs and legalized recreational cannabis for personal use last year.
Medical hashish markets have benefited from this replacement in the law, as it has mitigated medical hashish.
North American corporations also have to invest in the German market.
Earlier this month, Canada-based cannabis company High Tide entered the German medical cannabis market by acquiring a 51% stake in Frankfurt-based pharmaceutical company Purecan.
A report by Hachís Bloomwell Group published this month analyzes the advances that have occurred in this industry only in the last year.
With medical cannabis being increasingly used to treat health-related conditions, access is now easier through digital platforms where patients receive physician-supervised treatments manufactured to pharmaceutical standards.
The report identifies a diversification of medical hashish strains provided 2024.
In addition, Worths has fallen regularly, appearing a well begged market despite the previously safe fluctuations this year, the Gram value is € 9. 27 ($ 9. 72) in January to € 8. 35 ($ 8. 76) in November. For the first time, an indexed tension at € 3. 99 ($ 4. 19) consisting of Gram.
With the reclassification of medical hashish as non-narcotic, which led to an unprecedented increase in the number of prescriptions, the number of prescriptions issued in pharmacies increased by more than 1,000% in December 2024, more than in March of the same year. evidence that regulatory advances caused a radical change in the terms of access.
One of the other attractive aspects discovered in the report is the increasing demand for high levels of THC in strains. By the end of 2024, strains with THC content exceeding 25% made up almost a third of all orders, while the average THC concentration was 23. 35%.
Niklas Kouparanis, co-founder and CEO of Bloomwell Group, said in a press release that Germany’s hashish reforms can serve as a style for other European countries.
“We are at the beginning of a new era,” he said. Cannabis was a lot of years widely used years ago. After decades of stigmatization, the German government has introduced a replacement in our country that also serves as a style for progressive policies for other European countries. “
A poll conducted after the legalization of recreational cannabis in December 2024 showed that 59% of Germans support full legalization, marking the first increase in support since the cannabis reform took effect in April last year.
A community. Many voices. Create a free account to share your thoughts.
Our community is about connecting people through open and thoughtful conversations. We want our readers to share their views and exchange ideas and facts in a safe space.
To do this, please adhere to the posting regulations in our site’s terms of use. We’ve summarized some of those key regulations below. In other words, keep it civil.
Your message will be rejected if we realize that it seems to contain:
User accounts will be blocked if we notice or believe that users are engaged in:
So, how can you be a power user?
Thank you for reading our network policies. Please read the full list of publication rules discovered in the use situations of our site.